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Objective: To compare self-reports of immune-related diseases in DES daughters and controls. 
Prenatal exposure to diethylstilbestrol (DES) has been associated with several malformations in the 
lower genital tract, a higher prevalence of adenosis, and increased risk of clear cell adenocarcinoma, 
and estrogen-dependent tumors. Lately, reports have been published indicating a link between DES 
exposure and alterations in the immune system. The present study focuses on the possible clinical 
consequences of an affected immune system. Study design: DES daughters (N = 170) and control 
women (N = 123) completed questionnaires containing lists of immune related diseases, specified 
into three categories (i) allergies, (ii) auto-immune disorders, and (iii) infectious diseases. Results: 
DES daughters reported significantly more disease conditions than the controls. Analyses for separate 
disease categories (allergies, auto-immune disorders, infectious disease), yielded a statistical 
significant difference only for infectious disease. Within this last category, two infectious diseases 
yielded highly significant differences: bladder infection and measles. Conclusion: The present 
findings suggest that DES daughters are at higher risk to develop immune-related disease states.  
 
 




Prenatal exposure to DES has been demonstrated to be teratogenic and carcinogenic. It is associated 
with several malformations in the lower genital tract, including vaginal adenosis, ectopic columnar 
epithelium in the vagina, and a variety of anatomic deviations such as cervical collars and hoods, 
pseudopolyps of the cervix and cockscomb cervix (1-5). Exposure to large doses has been found to be 
related with a higher prevalence of adenosis. As the affected girls mature, the adenosis and cervical 
ectopy may be replaced by squamous metaplasia. In addition, there is evidence that the 
tubo-endometrial glands of vaginal adenosis may promote the onset of clear cell adenocarcinoma. 
Recent studies (6,7) have demonstrated increased risks of estrogen-dependent tumors, such as breast, 
vaginal, and cervical carcinoma in DES daughters and prostate and testicular carcinoma in DES sons. 
Recent animal research has further yielded evidence that DES exposure may also stimulate the 
development of prolactinomas (8). 
        In addition to the increased risk of a variety of somatic problems, DES daughters have been 
shown to be more vulnerable for mental disorders. For example, Vessey and coworkers (9) have 
demonstrated that even individuals unaware of their DES exposure were more likely to suffer from 
anxiety and depressive symptoms. Other studies have substantiated this picture, yielding evidence of 
increased risk of depression, diminished well-being, and more problems with relationships and 
sexuality in DES-exposed women than in control women. DES exposure is associated with a 
continuously ongoing source of worries concerning one's own health risks, pregnancy outcome, and 
the possible effects on one's offspring. Moreover, there is evidence that there is a greater proportion 
of left handers among prenatally DES-exposed individuals, possibly reflecting the influence of DES 
on the developing central nervous system (10, 11).  
 More recently, the attention of researchers has further focussed on endocrine and 
immunological abnormalities in DES daughters. Assies and associates (12) have provided some 
preliminary data indicating that these women are at increased risk for the development of 
hyperprolactinemia, associated with menstrual disorders, infertility, and primary hypothyroidism. 
Moreover, elevated plasma testosterone levels were detected in 40% of the subjects. In addition, 
Assies (13) and Wingard and Turiel (14) have reported on DES-related prolactinomas. Since both 
estrogens and prolactin are known to modulate immunological responses, it may be speculated that 
these women may have altered immune system responses, potentially leading to with a wide variety 
of immune-related diseases. Indeed several lines of evidence - experimental as well as clinical - 
indicate a link between DES exposure and alterations in immune system responses. Perinatal DES 
treatment has shown irreversible impairments in the immune system (15, 16). In animal studies, the 
main effects of DES consisted of a decreased number of T cells - particularly CD4 "helper" cells - 
and a reduced number of natural killer (NK) cells. In addition, reduced delayed cutaneous 
hypersensitivity reactions, graft versus host reactions, lymphocyte proliferative responses to T and B 
cell mitogens, and  diminished antibody production were observed. In old animals, tumors of the 
 
 
genital tract and mammary gland developed (17).  
 Studies with small samples of DES daughters have also suggested functional alterations in 
NK cells and a hyper-responsive immune system (18, 19). This would be consistent with the known 
effects of changes in prolactin level on lymphocyte proliferative response. For example, the 
administration of exogenous prolactin is associated with significant increments in lymphocyte 
proliferative response as well as with abolishment of the effects of immunosuppressive drugs. As 
would be expected, similar effects were observed with the administration of dopamine antagonists, 
such as the anti-psychotic drug perphenazine -- since dopamine normally inhibits prolactin release at 
the level of the pituitary. In line with these findings, decreased prolactin level associated with 
bromocriptine treatment (a dopamine receptor agonist) as well as treatment with cysteamine (a dithiol 
reducing agent inactivating prolactin) both demonstrated decrements in lymphocyte proliferative 
response. Further, bromocriptine administration has been associated with increased mortality after a 
Listeria challenge, and the use of anti-psychotic drugs has been suggested to account for studies 
showing that schizophrenics had a longer life span then the general population.    Until now, little 
attention has been paid to the prevalence of immune system-related diseases including allergies and 
hypersensitivity reactions, autoimmune disorders, and infectious diseases. Noller and associates have 
found that autoimmune diseases occur more frequently (about a twofold increase) in women with 
prenatal DES exposure compared with controls. Corresponding findings have been reported by 
Wingard and Turiel (14), who compared the results of the 1985 National Health Interview Survey and 
other population based studies on general health status among mothers, daughters, and sons exposed 
to DES. Asthma, arthritis, lupus, and diabetes mellitus were reported more frequently among the 
persons with DES exposure. In addition, the number of reported colds, flu, and respiratory tract 
conditions proved to be three times as high as control groups. Noller (20) found three infectious 
conditions differing between the exposed and control group. Candida infections and otitis media 
were more often reported by exposed women, which this author attributes to reporting bias. 
Surprisingly, kidney infection was found to occur more frequently among controls than among cases. 
Although one should always be aware of the bias toward pathology in samples participating in this 
kind of research, these data are nevertheless provocative and warrant further research in this area. 
        In the present study, the focus is also on self-reports of immune-related diseases. DES daughters 
and control women were asked to indicate whether they suffer from or - especially in the case of 
specific (childhood) infectious diseases - had suffered from diseases in which an important role of the 
immune system may be assumed. It is expected that the DES group would demonstrate a higher 




Subjects. Participants were 179 women who had been prenatally exposed to DES and who were 
 
 
registered in the Dutch DES Action Center in Utrecht, The Netherlands (age range 19 - 46; M = 30.0, 
SD = 6.1). Initially, 500 members of the DES Action Center were randomly selected and invited to 
participate. Omitting individuals not meeting study inclusion criteria (e.g., mothers, sons, the 
mentally retarded) and refusals, 208 questionnaires were sent out by mail -- yielding a response rate 
of 82%. 
 The control group consisted of 123 women who were acquaintances of the cases in the same 
age range (M = 32.0; SD = 6.0) and who had no known history of prenatal DES exposure. 
 
Measures. A list of diseases of the DES-exposed consisted of three categories: (1) allergies (e.g., hay 
fever, hives, contact allergies), (2) autoimmune disorders (e.g., diabetes, multiple sclerosis, 
rheumatoid arthritis), and (3) infectious diseases (e.g., measles, infectious mononucleosis, bladder 
infection) (see Table 1). Comparisons were made for each individual disease and for the summed 




Table 1a-c summarizes the disease prevalence rates in DES daughters and controls. In Table 2, the 
mean number of diseases within each category is presented. With the exception of infantile eczema 
and whooping cough, DES daughters report as many, but more often, a higher prevalence of diseases 
than the control group. Levels of statistical significance (Yates-corrected chi-squares) were only 
reached for measles and bladder infection. In addition, the total number of reported infectious 




The present study represents only a preliminary report of possible effects of prenatal DES exposure 
in women on the later occurrence of immune-related disorders. As expected DES daughters reported 
significantly more illnesses than the controls. This picture emerged for every disease category, but 
reached statistical significance only for infectious diseases. A more detailed look at the data revealed 
that two infectious diseases yielded highly significant differences: bladder infection and measles. 
Although the increased susceptibility to bladder infections may at least partly be attributed to the well 
known malformations and developmental abnormalities of the urogenital tract in DES daughters, it 
cannot be excluded that local immunological changes in the bladder mucosa and its transitional 
epithelium also play a role, as is known for the cervical mucosa and its columnar epithelium in the 
etiology of squamous cell carcinoma of the cervix (21) -- another condition associated with DES 
exposure.  
 Sex steroids are known to influence human immune mechanisms. Chronic infection with 
 
 
Candida albicans is common in women, especially during pregnancy. Mathur and coworkers (22) 
showed the production of antibodies to be specifically influenced by sex steroid hormones -- being 
enhanced by progesterone and estradiol at low levels, but depressed by estradiol at high levels. Very 
importantly, DES injection into rats with normal urinary tracts was shown to induce squamous 
metaplasia of the transitional epithelium of the bladder, distal and proximal ureters, varying degrees 
of hydronephrosis and an increased susceptibility to renal parenchymal infection (23). In contrast, it 
is far more difficult to speculate about the mechanisms responsible for the dramatic differences in 
measles infection rates. It is tempting to hypothesize that this increased susceptibility to measles 
reflects the hypothesized gender-specific effect of DES on the immune system, since boys, indeed, 
are known to be more susceptible to measles than non-DES-exposed girls. However, at the subjective 
level no evidence supporting a masculinizing effect of DES has been found in the present sample 
(24).  
   Another interesting aspect of the increased prevalence of measles in the DES group is related 
to the recent available evidence that there is an association between being infected by measles and 
viral-induced autoimmune diseases, including multiple sclerosis and -- possibly -- schizophrenia. Of 
note here is that paramyxoviruses, such as measles virus, have a known predilection to invade the 
CNS, resulting in CNS diseases -- i.e., subacute sclerosing panencephalitis in the case of measles 
virus (25).  
 Although the differences failed to reach statistical significance, it nevertheless may be 
notable that thyroid problems, multiple sclerosis and diabetes indeed did show a higher prevalence in 
the DES group -- in particular when expressed as relative risks. In Noller's study (26), the overall 
prevalence of any autoimmune disease was increased, but one disease in particular, Hashimoto's 
thyroiditis, occurred significantly more frequently among exposed women. The presence of vaginal 
epithelial changes (adenosis, metaplasia) is, in general, a marker for being exposed to higher DES 
doses. Women with vaginal epithelial changes had nearly 50% more autoimmune disease than DES 
exposed women without vaginal changes.         
 The present finding thus once more supports the hypothesis that prenatal DES exposure 
increases the risk of developing immune-related disorders. Whereas previous studies focused on 
allergic conditions and autoimmune disorders, the present study extends these findings to the realm of 
infectious diseases. In addition, there is growing interest in the consequences of DES exposure for the 
immune system. Animal work has yielded evidence of lifelong immunosuppression, as reflected in a 
reduced number of CD4 "T helper" cells and NK cells. Mice with neonatal exposure show impaired 
B cell response and a reduced ability to resist tumors. A limited number of human studies suggest a 
hyper-reactive immune response in DES daughters and indications for possible functional alterations 
in NK cells of clinical significance, which would be particularly important to viral infections and 
tumor development. 
   Whereas it is already established from a biomedical point of view that prenatally DES-
 
 
exposed individuals show an increased risk of immune-related diseases, looking at this issue from a 
psychoneuroimmunological perspective expands the potential risk for immune-related diseases. The 
picture that emerges is that these women showed increased levels of distress, as reflected in elevated 
scores on the Hopkins Symptom Checklist. The combination of a state of distress and an already 
compromised immune system may facilitate the onset of clinical symptoms, as occurs in HIV-1 
infection (27, 28). This situation may be exacerbated by a weakened family process in which a 
chronic family physical health stressor has been imposed -- the shared susceptibility to diseases 
associated with DES exposure. Further, if this stressor is met with passive rather than active coping 
strategies and with a lack of outside social support, this disposition toward high distress may be 
potentiated over time. An intriguing question, then, is to what extent psychosocial interventions 
might play a role in preventing the aforementioned process from occurring and, as a consequence, 
prevent or delay the onset of immune-related diseases in individuals with in utero exposure to DES.   
          
 It should be emphasized that this study demonstrates some serious limitations. It is a selective 
sample, because it includes only DES daughters who are involved in the organization. We are also 
aware of the limitations of this and many other studies, where there is a lack of detailed information 
about the actual DES dosage and the duration of exposure. Nevertheless, the results are suggestive 
and extend the data from prior work, which also showed an increased prevalence of a variety of 
immune-related diseases following in utero exposure to DES. Given these findings, we would like to 
stress the importance of immunoendocrinological studies of DES daughters, in order to obtain a 
better insight into mechanisms that may be responsible for the greater disease susceptibility. We 
would emphasize that DES daughters who are very distressed and concerned about their future 
health, have the right to be taken seriously by health care workers and, when needed, to get extra 
attention and support. This is not only a task for the DES Action Centers, but also for general 




1. Emens JM. Continuing problems with diethylstilbestrol Br J Obstet Gynaecol 1994;101:748-50 
2. Giusti RM, Iwamoto K, Hatch EE. Diethylstilbestrol revisited: A review of the long-term health 
effects. Ann Intern Med 1995;122:778-88. 
3. Herbst AL. Problems of prenatal DES exposure. In: Herbst AL, Mishell DR, Stenchever MA, 
Drögemüller W, editors. Comprehensive gynecology. St. Louis, MI: Mosby Year Book, 1992:409-23. 
4. Kaufman RH, Binder GL, Gray PM, Adam E. Upper genital tract changes associated with 
exposure in utero to diethylstilbestrol. Am J Obstet Gynecol 1977;128:51-9. 
5. Mittendorf R. Teratogen update: Carcinogenesis and teratogenesis associated with exposure to 
diethylstilbestrol (DES) in utero. Teratology 1995;51:435-45. 
6. Marselos M, Tomatis L. Diethylstilbestrol I: Pharmacology, toxicology and carcinogenecity 
inhumans. Eur J Cancer 1992;28A:1182-9. 
7. Verheijen RHM, Schijf CPT, Van Dongen PWJ, Van der Zanden PHT, Bakker EHM. 
Gynaecologische en obstetrische consequenties van blootstelling aan diethylstilbestrol (DES) in utero 
herbelicht. Ned T Gen 1991;135:89-93.  
8. Walker BE, Kurth L. Pituitary tumors in mice exposed prenatally to diethylstilbestrol. Cancer Res 
1993;53:1546-9. 
9. Vessey MP, Fairweather DVI, Norman-Smith B, Buckley J. A randomized double-blind trial of the 
value of stilboestrol therapy in pregnancy: Long-term follow-up of mothers and their offspring. Br J 
Obstet Gynecol 1983;90:1007-17. 
10. Schachter SC. Handedness in women with intrauterine exposure to diethylstilbestrol. 
Neuropsychologia 1994;32:25-34 
11. Scheirs JGM, Vingerhoets AJJM. Handedness and other laterality indices in women prenatally 
exposed to DES. J Clin Exp Neuropsychol 1995;17:725-30 
12. Assies J, Vonk J, Bleker O, Lumey L. Diethylstilbestrol (DES) related endocrine disturbances in 
women. Ann New York Acad Sci 1995;761:369-72. 
13. Assies J. Hyperprolactinaemia in diethylstilbestrol-exposed women. Letter to the editor. Lancet 
1991;337:983. 
14. Wingard DL, Turiel J. Long-term effects of exposure to Diethylstilbestrol. West J Med 
1988;149:551-4. 
15. Blair BP. Immunological consequences of early exposure of experimental rodents to 
diethylstilbestrol and steroid hormones. In Bern HA, Herbst AL, editors. Developmental effects of 
Diethylstilbestrol (DES) in pregnancy. New York: Thieme Stratton, 1981:167-78. 
16. Blair PB. Immunologic consequences of prenatal exposure to hormones. In Giusti RM, editor. 
Report of the NIH workshop on long-term effects of exposure to diethylstilbestrol (DES).  




17. Kalland T, Holmdahl R. Estrogens and immunity: Long-term consequences of neonatal 
imprinting of the immune system by diethylstilbestrol. In Mori T, Nagasawa H, editors. Toxicity of 
hormones in perinatal life. Boca Raton Fl: CRC Press Inc., 1988:111-25. 
18. Ford CD, Johnson GH, Smith WG. Natural killer cells in utero diethylstilbestrol-exposed patients. 
Gynecol Oncol 1983;16:400-4. 
19. Ways SC, Mortola JF, Zvaifler NJ, Weiss RJ, Yen SS. Alterations in immune responsiveness in 
women exposed to diethylstilbestrol in utero. Fertil Steril 1987;48:193-7. 
20. Noller KL. Medical and surgical diseases in DES-exposed women. In Giusti RM, editor. Report 
of the NIH workshop on long-term effects of exposure to diethylstilbestrol (DES).  Washington DC: 
US Department of Health and Human Services, Public Health Service, NIH, 1992:34-5. 
21. Goodkin K, Antoni MH, Sevin B, Fox BH: A partially testable model of psychosocial factors in 
the etiology of cervical cancer. I. Biological, psychological and social aspects. Psycho-Oncology 
1993;2:79-98. 
22. Mathur S, Mathur RS, Dowda H, Williamson HO, Faulk WP, Fudenberg HH. Sex steroid 
hormones and antibodies to Candida albicans. Clin Exp Immunol 1978;33:79-87 
23. Andriole VT, Cohn GL. The effect of diethylstilbestrol on the susceptibility of rats to 
hematogenous pyelonephritis. J Clin Invest 1964;43:1136-45. 
24. Bekker M, Van Heck GL, Vingerhoets AJJM. (1996). Gender identity, body experience, 
sexuality, and the wish for getting children in DES-daughters. Women & Health (in press). 
25. Harrowe G, Mitsuhashi M, Payan DG. Measles virus-substance P receptor interactions. J Clin 
Invest 1990; 85:1324-7. 
26. Noller KL, Blair PB, O'Brien PC, Melton LJ, Offord JR, Kaufman RH et al. Increased occurrence 
of autoimmune disease among women exposed in utero to diethylstilbestrol. Fertil Steril 
1988;49:1080-2. 
27. Goodkin K, Fletcher MA, Cohen N. Clinical aspects of psychoneuroimmunology. Lancet  
1995;345:183-4. 
28. Goodkin K, Antoni MH, Sevin B, Fox BH: A partially testable model of psychosocial factors in 
the etiology of cervical cancer. II. Psychoneuroimmunological aspects, critique and prospective 
integration. Psycho-Oncology 1993;2:99-121. 
Table 1(a-c). Self-reported prevalences (percentages) of diseases in DES daughters and controls. In 
addition, Yates corrected chi-squares are reported.  
 
A. Allergies          Controls   DES    Chi-sq    p 
          N = 123 N = 170 
1. hay fever    16  20 0.77  ns        
2. chronic rhinitis         12 16 0.78  ns 
3. asthma                 9 11 0.01  ns 
 
 
4. hives                7 12 1.37  ns        
5. eczema                   24  25 0.00  ns 
6. contact allergy  
   (rubber, cosmetics, etc)  22 32 2.74 .09 
7. hypersensitivity to food  
   or medication   20 23 0.01  ns 
8. hypersensitivity other  e.g., cat  
   hairs,  sting of bees, etc)  20 29 2.60 .11 




B. Autoimmune disorders 
1. thyroid problems   3       8     1.07    ns 
2. rheumatoid disorders  4       4     0.00    ns 
3. multiple sclerosis   0       6     2.66    .10 
4. diabetes    1       3     0.63    ns 




C. Infectious disease 
1. influenza (past 2 years)  57 62 0.54 ns 
2. mumps    42 46 0.45 ns 
3. rubella    38 43 0.62 ns 
4. whooping cough   11  8 0.54 ns 
5. measles    49 69 11.90   <.001 
6. jaundice     7  8 0.00 ns 
7. chicken pox    60 63 0.27 ns 
8. herpes zoster    5  8 0.42 ns  
9. herpes simplex - 1   27 27 0.00 ns 
10. herpes simplex - 2    4  5 0.00 ns 
11. infectious mononucleosis   9  9 0.00 ns 
12. (chronic) bronchitis  14 21 2.61 ns 
13. pneumonia    10 15 1.27 ns 
14. bladder infection   35 50 5.54    <.02 
15. otitis media   28 34 1.08 ns 
16. fungal infections   49 51 0.09 ns 




Table 2. Summary of the mean number of diseases reported by DES daughters and Controls.           
     Controls DES  t-value   p  
Total number of reported diseases 8.23 9.74 2.96 <.01 
Total allergies    1.66 2.03 1.44  ns 
Total autoimmune disorders  0.10 0.19 1.22  ns 
Total infectious disease  6.52 7.52 2.95 <.01 
